ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NRXPW NRX Pharmaceuticals Inc

0.0873
0.00 (0.00%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -9.6M-9.14M-9.89M-9.44M-8.19M-5.81M-4.41M-6M
Pre Tax Income -6.98M-9.08M-10.24M-11.04M-8.72M-6.06M-4.33M-6.53M
Net Income -6.98M-9.08M-10.24M-11.04M-8.72M-6.06M-4.34M-6.53M
Preferred Dividends 000000-9k0
Basic Earnings Per Share (EPS) 00000000
EBIT -7.12M-9.14M-10.39M-11.21M-8.85M-6.17M-4.32M-6.32M
EBITDA -9.6M-9.14M-9.89M-9.43M-8.19M-5.81M-4.41M-6M
Year End December 30 2023 2017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00010.16M771k00
Operating Income -134k-1.01M-713k-51.39M-115.8M-44.34M-27.84M
Pre Tax Income -105k82k492k-51M-93.06M-39.75M-30.15M
Net Income -105k66k408k-51M-348.89M-39.75M-30.16M
Preferred Dividends 0000-255.82M0-9k
Basic Earnings Per Share (EPS) -0.0410.0240.143-18.972-5.673-0.575-0.348
EBIT -134k-1.01M-713k-51.05M-94.86M-40.26M-30.54M
EBITDA -134k-1.01M-713k-51.39M-115.79M-44.33M-27.83M

Your Recent History

Delayed Upgrade Clock